Hypoglycemia: Clinical Trials

685 trials for Hypoglycemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

446 completed, 53 unknown, 52 terminated, 50 recruiting. 290 Not applicable, 113 Phase 2, 63 Phase 1, 57 Phase 3, 49 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable290Completed 193, Terminated 23, Unknown 23, Recruiting 20, Withdrawn 12, Not yet recruiting 10, Active not recruiting 3, Enrolling by invitation 3, Suspended 3
Phase 2113Completed 70, Terminated 14, Withdrawn 14, Recruiting 6, Active not recruiting 4, Not yet recruiting 3, Suspended 1, Unknown 1
Phase 163Completed 40, Terminated 8, Recruiting 4, Withdrawn 4, Active not recruiting 2, Not yet recruiting 2, Suspended 2, Unknown 1
Phase 357Completed 36, Terminated 7, Recruiting 5, Unknown 4, Withdrawn 3, Active not recruiting 2
Phase 449Completed 34, Unknown 6, Terminated 4, Withdrawn 2, Active not recruiting 1, Not yet recruiting 1, Recruiting 1
Early Phase 115Completed 7, Recruiting 5, Active not recruiting 1, Unknown 1, Withdrawn 1

Follow Hypoglycemia: new trials by email Literature Review of Hypoglycemia trials Research Report on Hypoglycemia

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Behavioural Problems and Cognition in Children With Hypoglycemia Unawareness in Type-1 Diabetes Mellitus
Psychological Interventions for children and adolescents - Type 1 Diabetes
Not applicableNot yet recruitingUniversity of Pittsburgh502026-12-012026-07-07
The BRIGHT Study (Device Name: HALO System)
The HALO System - Diabetes Mellitus - Type 1, Diabetes Mellitus - Type 2
Not applicableNot yet recruitingIndigo Diabetes NV122026-12-012026-08-04
Study of the Safety and Efficacy of Pancreatic Endocrine Cells in Adult Patients With Type 1 Diabetes
Allogeneic pancreatic endocrine cell clusters - Diabete Mellitus, Diabete Type 1
Phase 1 / Phase 2Not yet recruitingSeraxis92026-11-012026-10-19
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PAL-119 in Healthy Volunteers and Adult Participants With Type 1 or Type 2 Diabetes
PAL-119, Placebo - Healthy Volunteers and Diabetes Participants
Phase 1 / Phase 2Not yet recruitingPaulex Bio Inc.1472026-11-012026-10-28
Comparing Glycemic Outcomes of Carbohydrate Counting vs. Fixed Mealtime Insulin Dosing in Hospitalized Patients With Hyperglycemia
Carbohydrate-counting-based prandial rapid-acting insulin dosing, Flexible fixed mealtime rapid-acting insulin dosing based on percentage of meal consumed - Diabetes Type 2 on Insulin, Hypoglycemia (Diabetic)
Not applicableNot yet recruitingMayo Clinic5002026-10-012026-09-08
Enhancing Shared Decision-making to Guide Care for People With Dementia and Diabetes
Continuous Glucose Monitoring - Diabetes, Alzheimer's Disease (Incl Subtypes)
Not applicableRecruitingIndiana University622026-09-292026-10-05
Umbilical Cord Glucose
For the screening, the interventions will be glucose measurements (and possibly G-BOBH), while follow-up assessments will include Bayley testing, EEG, and MRI. - Congenital Hyperinsulinism (CHI)
Not applicableNot yet recruitingOdense University Hospital502026-09-012026-08-31
Implementation of Networked Continuous Glucose Monitoring With Telemetry Within the Intensive Care Unit (ICU-TeleCGM)
Dexcom G7, ViewsEMR telemetry - Type 1 Diabetes, Type 2 Diabetes Treated With Insulin
Not yet recruitingImperial College Healthcare NHS Trust702026-08-012026-08-17
Perioperative Hypoglycemia in Diabetic Patients Undergoing Vitrectomy: a Masked CGM Prospective Observational Study
Masked continuous glucose monitoring (FreeStyle Libre 2®) - Diabetes Mellitus, Hypoglycemia
Not yet recruitingYonsei University852026-07-152026-07-10
Anakinra for the Treatment of Postprandial Hypoglycemia in a Patient With Total Gastrectomy and End-Stage Renal Disease
Anakinra (interleukin-1 receptor antagonist), Placebo Comparator (0.9% NaCl) - Postprandial Hypoglycemia, End-stage Renal Disease (ESRD)
Phase 2Not yet recruitingMarc Donath12026-07-012026-05-12
Closed Loop Glucose Control in a Simulated ICU Setting
FUSION closed loop glucose control system - Type 1 Diabetes, Type 2 Diabetes
Not applicableNot yet recruitingIdeal Medical Technologies62026-07-012026-06-12
GlycoQuest: An AI-Adaptive CGM-Integrated Serious Game for Pediatric Type 1 Diabetes
GlycoQuest Digital Therapeutic, Enhanced Digital Psychoeducation - Type 1 Diabetes Mellitus (T1DM), Diabetes Distress
Not applicableRecruitingShifa International Hospital1102026-06-012026-07-24
Developing a Colonoscopy Preparation Protocol for Patients With Diabetes
timing of cleansing and procedure - Hypoglycaemia, Diabete Mellitus
Not applicableNot yet recruitingQueen's University402026-06-012026-04-24
Miniaturized Breath-based Sensor for the Detection of Hypo- and Hyperglycemia
Sensing Device and Tedlar Bags - Diabetes, Hyperglycemia
Not applicableRecruitingIndiana University402026-05-312026-07-10
Hypoglycemia Fear Affect Autonomic Function, Physical Activity, and Exercise Capacity in Type I Diabetes
No intervention (observational study) - Type 1 Diabetes Mellitus
Not yet recruitingOrdu University672026-05-022026-04-14
FEAR of HYPOGLYCEMIA in PATIENTS WITH DIABETES
Diabetes Mellitus, Diet, Healthy
RecruitingBilecik Seyh Edebali Universitesi1002026-04-152026-09-16
A Study of Endocrine, Metabolic, and Genetic Risk Factors of Pediatric Persistent Hypoglycemia at Sohag University Hospital
Hypoglycaemia
Not yet recruitingSohag University502026-04-152026-04-16
Validation of Remote Photoplethysmography for Non-Invasive Estimation of Blood Glucose and HbA1c
Diabetes Mellitus, Hyperglycaemia (Diabetic)
Not yet recruitingTarumanagara University3002026-03-232026-04-20
The Real-World Control-IQ Glycemic Control and Quality of Life Study in Type 1 Diabetes in France
t:slim X2 insulin pump with Control-IQ technology (Control-IQ System) - Diabetes Mellitus, Type 1
RecruitingTandem Diabetes Care, Inc.3502026-03-032026-10-14
Effect of Ambient Temperature on Blood Glucose and Insulin Absorption in Adults With Type 1 Diabetes
Environmental Temperature Exposure - Type 1 Diabetes Mellitus
Not applicableNot yet recruitingInstitut de Recherches Cliniques de Montreal302026-03-012026-03-24

Showing 20 of 685. Sign in to see all of them.

Narrower conditions

Diabetes Mellitus, Type 1 (265)  ·  Diabetes Mellitus (138)  ·  Hyperglycemia (110)  ·  Diabetes Mellitus, Type 2 (88)  ·  Insulin Resistance (56)  ·  Motor Activity (48)  ·  Congenital Hyperinsulinism (37)  ·  Hyperinsulinism (23)  ·  Glucose Metabolism Disorders (17)  ·  Diabetes Complications (13)  ·  Critical Illness (12)  ·  Insulinoma (12)  ·  Metabolic Diseases (12)  ·  Fasting (9)

Broader conditions

Nutritional and Metabolic Diseases (685)  ·  Metabolic Diseases (673)  ·  Glucose Metabolism Disorders (668)  ·  Endocrine System Diseases (439)  ·  Diabetes Mellitus (289)  ·  Immune System Diseases (270)  ·  Autoimmune Diseases (261)  ·  Hyperinsulinism (80)  ·  Pathological Conditions, Signs and Symptoms (79)  ·  Behavior (75)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (57)  ·  Digestive System Diseases (55)  ·  Pathologic Processes (54)  ·  Pancreatic Diseases (44)  ·  Infant, Newborn, Diseases (42)

Interventions

Insulin (35)  ·  Glucagon (32)  ·  Continuous Glucose Monitoring (26)  ·  Insulin Aspart (22)  ·  Glucagon-Like Peptide 1 (17)  ·  Insulin Glargine (17)  ·  dasiglucagon (16)  ·  Sodium Chloride (14)  ·  Exercise (13)  ·  Glucose (13)  ·  exendin (9-39) (12)  ·  Insulin, Regular, Human (10)  ·  Islets of Langerhans Transplantation (10)  ·  fluorodopa F 18 (9)  ·  Methods (8)

Sponsors

Institut de Recherches Cliniques de Montreal (27)  ·  Steno Diabetes Center Copenhagen (17)  ·  University of Minnesota (15)  ·  Joslin Diabetes Center (14)  ·  Zealand Pharma (14)  ·  Insel Gruppe AG, University Hospital Bern (12)  ·  Xeris Pharmaceuticals (11)  ·  Yale University (11)  ·  Eli Lilly and Company (10)  ·  Jaeb Center for Health Research (10)  ·  Florida Atlantic University (8)  ·  Brigham and Women's Hospital (7)  ·  University Hospital, Basel, Switzerland (7)  ·  Indiana University (6)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (6)

Countries

United States (281)  ·  Canada (71)  ·  Denmark (62)  ·  United Kingdom (45)  ·  Switzerland (34)  ·  France (32)  ·  Germany (31)  ·  Israel (19)  ·  Netherlands (19)  ·  Turkey (Türkiye) (16)  ·  China (14)  ·  Italy (12)  ·  Spain (12)  ·  Belgium (9)  ·  Saudi Arabia (9)

Top investigators

Bernhard J. Hering, M.D. (5)  ·  Christoph Stettler, MD (5)  ·  Christoph Stettler, Prof. MD (5)  ·  John Lum, MS (5)  ·  Remi Rabasa-Lhoret (5)  ·  Stephen N. Davis, MD (5)  ·  Betty Tuller, PhD (4)  ·  Bruce A Buckingham, MD (4)  ·  Eyal Dassau, PhD (4)  ·  Mary Elizabeth Patti, MD (4)  ·  Robert Sherwin, MD (4)  ·  Rubina Heptulla, MD (4)

Results publications

PMID 15793249, PMID 17339500, PMID 2012085, PMID 21388440, PMID 22996144, PMID 23438305, PMID 25393157, PMID 28941330, PMID 31615852, PMID 34282646, PMID 34620618, PMID 36482870, PMID 37166980, PMID 37526194, PMID 38635313, PMID 39780302, PMID 10371488, PMID 11023138, PMID 11315822, PMID 11889147, PMID 1494764, PMID 14961992, PMID 15138460, PMID 15713772, PMID 15857224, PMID 15920041, PMID 16241867, PMID 16302286, PMID 16373890, PMID 16505513, PMID 16800753, PMID 17003293, PMID 17065680, PMID 17192346, PMID 17236890, PMID 17416785, PMID 17513708, PMID 17519307, PMID 17583795, PMID 17659061, PMID 17682088, PMID 17717285, PMID 17895314, PMID 18332163, PMID 18456072, PMID 18512043, PMID 18594062, PMID 18703486, PMID 18786961, PMID 19056608

NIH funding

2019 (4), R01DK085591 (4), 2017 (3), K24HL103845 (3), R01DK069803 (3), R01DK091331 (3), 2025 (2), R01DK020495 (2), R01DK079974 (2), R01DK137518 (2), R01HL109634 (2), R37DK020495 (2), T32HL007609 (2), UL1TR001102 (2), 2005 (1)